Key result
Aronia melanocarpa seed oil attenuates doxorubicin-induced cardiomyocyte apoptosis, reducing caspase-3 expression by ~89%.
Why the study?
The protective effects of Aronia melanocarpa seed oil against doxorubicin-induced cardiotoxicity and its molecular mechanisms were not well understood.
Does Aronia melanocarpa seed oil pretreatment prevent doxorubicin-induced cardiotoxicity and apoptosis in H9c2 cells?
Does Aronia melanocarpa seed oil pretreatment prevent doxorubicin-induced cardiotoxicity and apoptosis in H9c2 cells?
Aronia melanocarpa seed oil attenuates doxorubicin-induced apoptosis in H9c2 cardiomyoblasts in vitro, highlighting its potential as a natural cardioprotective agent against chemotherapy-induced cardiotoxicity.
Answers are grounded in this paper and cite their sources.
Does not support clinical use against doxorubicin cardiotoxicity; leaves open cardioprotective potential of Aronia melanocarpa seed oil for future studies.
Purpose: This study aimed to investigate the protective effects of Aronia melanocarpa (chokeberry) seed oil (ASO) against doxorubicin (DOX)-induced cardiotoxicity in H9c2 cells by evaluating apoptosis-related mRNA expression and assessing the potential interactions of ASO-derived fatty acids with apoptosis-related proteins using molecular docking.Materials and Methods: ASO cytotoxicity was assessed using the MTT assay, and concentrations of 10, 25, and 50 µg/mL were selected for further experiments based on the IC₅₀ value (377 µg/mL). H9c2 cells were pretreated with ASO for 30 min before exposure to 5 µM DOX for 24 h. Cell viability was assessed using the MTT assay, and the mRNA expression levels of caspase-3, Bax, and Bcl-2 were determined using RT-qPCR. Molecular docking analyses were performed to evaluate the binding affinities of ASO-derived fatty acids toward apoptosis-related proteins.Results: DOX increased caspase-3 and Bax mRNA expression (~3.31-fold and ~1.62-fold vs. control, respectively) while decreasing Bcl-2 expression (~0.42-fold vs. control). ASO pretreatment dose-dependently attenuated these alterations, with the strongest effects observed at 50 µg/mL, reducing caspase-3 and Bax mRNA expression (~0.36-fold and ~0.64-fold vs. DOX, respectively) while increasing Bcl-2 expression (~2.14-fold vs. DOX). In addition, ASO increased the Bcl-2/Bax ratio compared with the DOX-treated group (~1.25-, ~2.62-, and ~3.31-fold vs. DOX at 10, 25, and 50 µg/mL, respectively). Molecular docking demonstrated potential interactions between ASO-derived fatty acids and apoptosis-related proteins, with binding energies ranging from −4.8 to −5.8 kcal/mol.Conclusion: ASO attenuated DOX-induced apoptotic responses by modulating apoptosis-related mRNA expression, supporting its potential as a natural cardioprotective agent. Further in vivo studies are warranted to confirm these findings and clarify the underlying cardioprotective mechanisms.
No takes yet. Share an insight, caveat, or question.
Gökmen et al. (2026) studied Doxorubicin-induced cardiotoxicity. Aronia melanocarpa seed oil (ASO) vs. Doxorubicin (DOX) alone was evaluated on Caspase-3 mRNA expression (~0.36-fold vs DOX, p=<0.0001). Aronia melanocarpa seed oil pretreatment at /mL attenuated doxorubicin-induced apoptosis in H9c2 cells by reducing caspase-3 and Bax mRNA expression and increasing Bcl-2 expression.
Synapse has enriched 10 related papers. Consider them for comparative context: